Abbott Laboratories (ABT) said it is rolling out a laboratory-based blood test which can detect antibodies designed to identify whether someone has had the coronavirus strain Covid-19. The digital device maker is planning to ramp up manufacturing to produce 20 million tests by June.Shares of the healthcare company, which is scheduled to report first-quarter earnings on Thursday, rose 2% to $90.94 a share, while the NYSE Composite Index dropped 2.9%. Analysts expect Abbott to earn an average 58 cents per share in the quarter.The company announced that it expects to ship close to 1 million tests this week to hospitals …read more
Source:: Yahoo Finance
